10.00Open10.00Pre Close0 Volume0 Open Interest25.00Strike Price0.00Turnover245.57%IV-2.46%PremiumMay 16, 2025Expiry Date10.36Intrinsic Value100Multiplier10DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8608Delta0.0369Gamma1.37Leverage Ratio-0.0614Theta-0.0053Rho-1.18Eff Leverage0.0055Vega
RxSight Stock Discussion
RxSight Cuts 2025 Revenue Target by $25M Despite Strong Lens Sales Growth
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S (ASND.US)$
$Vaxcyte (PCVX.US)$
$Legend Biotech (LEGN.US)$
$Janux Therapeutics (JANX.US)$
$Aerovate (AVTE.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Evolent Health (EVH.US)$
$NewAmsterdam Pharma (NAMS.US)$
$RxSight (RXST.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Edgewise Therapeutics (EWTX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Biogen (BIIB.US)$
$PepGen (PEPG.US)$